AcquisitionOther
Servier acquired Day One Biopharmaceuticals, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Servier -> Day One Biopharmaceuticals, Inc. · approximately $2.5 billion
Reinforces position in rare oncology and expands pipeline with programs targeting adult and pediatric cancers with high unmet needs.
Open source record (SEC) ↗